GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:541540) » Definitions » Pretax Margin %

Solara Active Pharma Sciences (BOM:541540) Pretax Margin % : 2.69% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Solara Active Pharma Sciences's Pre-Tax Income for the three months ended in Dec. 2024 was ₹81 Mil. Solara Active Pharma Sciences's Revenue for the three months ended in Dec. 2024 was ₹3,003 Mil. Therefore, Solara Active Pharma Sciences's pretax margin for the quarter that ended in Dec. 2024 was 2.69%.

The historical rank and industry rank for Solara Active Pharma Sciences's Pretax Margin % or its related term are showing as below:

BOM:541540' s Pretax Margin % Range Over the Past 10 Years
Min: -39.44   Med: 4.09   Max: 14.06
Current: -13.02


BOM:541540's Pretax Margin % is ranked worse than
75.05% of 974 companies
in the Drug Manufacturers industry
Industry Median: 6.085 vs BOM:541540: -13.02

Solara Active Pharma Sciences Pretax Margin % Historical Data

The historical data trend for Solara Active Pharma Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Pretax Margin % Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin %
Get a 7-Day Free Trial 9.06 14.06 -7.40 -3.25 -39.44

Solara Active Pharma Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -129.91 -66.96 -3.70 2.31 2.69

Competitive Comparison of Solara Active Pharma Sciences's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's Pretax Margin % falls into.


;
;

Solara Active Pharma Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Solara Active Pharma Sciences's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-4884.2/12383.9
=-39.44 %

Solara Active Pharma Sciences's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=80.9/3003.1
=2.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solara Active Pharma Sciences  (BOM:541540) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Solara Active Pharma Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences Business Description

Traded in Other Exchanges
Address
27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines